Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration and the Risk of Stroke: A 5-Year Follow-up Cohort Study

被引：0
|
作者：
Kim, Sung Soo [1 ]
Rim, Tyler Hyungtaek [1 ]
Lee, Christopher Seungkyu [1 ]
Lee, SungChul [1 ]
Kim, Do Wook [1 ]
Park, Hyun Ju [1 ]
机构：
[1] Yonsei Univ, Coll Med, Inst Vis Res, Dept Ophthalmol,Severance Hosp, Seoul, South Korea
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2016年 / 57卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
547
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Correction to: Disengagement and loss to follow-up in intravitreal injection clinics for neovascular age-related macular degeneration
    Rebecca Jones
    Irene M. Stratton
    Peter H. Scanlon
    Sofia Theodoropoulou
    Eye, 2023, 37 : 3297 - 3297
  • [22] Risk factors for progression from early and intermediate to late age-related macular degeneration: 5-year follow-up in the EUGENDA cohort
    Kersten, E.
    Sitnilska, V.
    Altay, L.
    Schick, T.
    Enders, P.
    de Jong, E. K.
    Langmann, T.
    den Hollander, A. I.
    Fauser, S.
    Hoyng, C. B.
    ACTA OPHTHALMOLOGICA, 2019, 97 : 12 - 12
  • [23] Intravitreal Therapy in Bilateral Neovascular Age-Related Macular Degeneration
    Barthelmes, Daniel
    Walton, Richard J.
    Arnold, Jennifer J.
    Mcallister, Ian L.
    Simpson, Judy M.
    Campain, Anna
    Hunyor, Alex P.
    Guymer, Robyn
    Essex, Rohan W.
    Morlet, Nigel
    Gillies, Mark C.
    OPHTHALMOLOGY, 2014, 121 (10) : 2073 - 2074
  • [24] Three-Year Visual Outcome and Injection Frequency of Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration
    Muniraju, Ramu
    Ramu, Jayashree
    Sivaprasad, Sobha
    OPHTHALMOLOGICA, 2013, 230 (01) : 27 - 33
  • [25] Incidence and Risk Factors for Macular Hemorrhage Following Intravitreal Ranibizumab Injection for Neovascular Age-Related Macular Degeneration
    Moon, Sang Woong
    Oh, Jaeryung
    Yu, Hyeong Gon
    Cho, Hee Yoon
    Song, Su Jeong
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2013, 29 (06) : 556 - 559
  • [26] Prevention Surpasses Treatment: 5-year Follow-Up, Cost-Utility, and Cost–Benefit of Zeaxanthin Therapy for Neovascular Age-Related Macular Degeneration
    Gary C. Brown
    Melissa M. Brown
    Dennis Gierhart
    R. Joseph Olk
    Ophthalmology and Therapy, 2023, 12 : 2583 - 2608
  • [27] Intravitreal bevacizumab therapy for neovascular age-related macular degeneration:: a pilot study
    Abraham-Marin, Maura Lucy
    Cortes-Luna, Carlos Fernando
    Alvarez-Rivera, Griselda
    Hernandez-Rojas, Myriam
    Quiroz-Mercado, Hugo
    Morales-Canton, Virgilio
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2007, 245 (05) : 651 - 655
  • [28] Intravitreal bevacizumab therapy for neovascular age-related macular degeneration: a pilot study
    Maura Lucy Abrahám-Marin
    Carlos Fernando Cortés-Luna
    Griselda Álvarez-Rivera
    Myriam Hernández-Rojas
    Hugo Quiroz-Mercado
    Virgilio Morales-Cantón
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2007, 245 : 651 - 655
  • [29] Ranibizumab therapy for predominantly hemorrhagic neovascular age-related macular degeneration
    Dikmetas, Ozlem
    Kadayifcila, Sibel
    Eldem, Bora
    Feyzullayeva, Ulkar
    NORTHERN CLINICS OF ISTANBUL, 2022, 9 (02) : 173 - 179
  • [30] Effects of Combination Therapy with Intravitreal Ranibizumab and Tissue Plasminogen Activator for Neovascular Age-Related Macular Degeneration
    Ando, Michiko
    Kato, Aki
    Kimura, Masayo
    Ogura, Shuntaro
    Kuwayama, Soichiro
    Kominami, Aoi
    Kuwayama, Satoshi
    Obayashi, Tomohiro
    Ando, Ryota
    Monoe, Takafumi
    Morita, Hiroshi
    Yasukawa, Tsutomu
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (08)
12345